🇺🇸 FDA
Company

Option

Option Therapeutics

OPTN pharma USA

Quick answer

Option is a pharma company (OPTN) headquartered in CARSON CITY, NV, USA with 1 tracked pipeline programs.

Pipeline (1)

project

Intravenous Immunoglobulin

Autoimmune Epilepsy

Phase 3 · small_molecule · terminated

1 trials

Patents (8)

patent

US 11596610

Compositions in support of health and mental accuity

Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10117937

Highly branched alpha-D-glucans

Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9289513

Targeted cytokine for treatment of musculoskeletal diseases

Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8685932

Targeted transforming growth factor-beta-bound IgG for Treatment of Diseases

Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 6770283

DNA expression systems based on alphaviruses

Expires Mon Jul 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 6692750

Alphavirus expression vector

Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 6566093

Alphavirus cDNA vectors

Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 6224879

Alphavirus expression vector

Expires Mon Apr 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)